Apomorphine inhalation (Oncotelic Therapeutics)

N/A

Report date: 2025/01/14 15:50:19

Base Information

Drug NameApomorphine inhalation (Oncotelic Therapeutics)
Drug Alias NameAL-101 (Oncotelic Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine receptors agonists
TargetsDopamine receptors
Therapy Area/IndicationsSexual Dysfunctions, PsychologicalErectile DysfunctionParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesAutotelicbio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOncotelic Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSexual Dysfunctions, PsychologicalErectile DysfunctionParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A